Abstract—Increasing evidence has suggested that locally produced angiotensin II (Ang II) plays an important role in the development of cardiac hypertrophy through the Ang II type 1 receptor (AT1).We ...

A study from Canada has raised concerns about certain blood pressure medications possibly being linked to a higher risk of ...

What do I need to do to get disability benefits from Social Security? I’m 60 years old and have a medical condition that ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

Type II tumors generally are less well differentiated and have poorer prognoses than type I tumors, and they account for a disproportionate number of endometrial cancer deaths (40% of deaths, whereas ...

The newly approved product is a generic version of GIAPREZA, originally developed by La Jolla Pharma LLC, and is intended for use in critical care settings.

Richard Lafayette, MD, FACP, explains why a REMS program is not required for the endothelin A receptor antagonist and how ...

Researchers at the University of Tsukuba have developed a novel mouse model that allows them to induce dysfunction in only ...

Gland Pharma shares gained 3.2 per cent in trade on Tuesday, logging an intraday high at ₹1,800 per share on BSE. The stock ...

Earlier this month, the company's material subsidiary Cenexi also received a final inspection report from France's drug ...

Angiotensin II-receptor antagonists are well tolerated and are as effective as ACE inhibitors in decreasing blood pressure. Introduction. High blood pressure affects over 50 million Americans, but ...

Cite this: Angiotensin II-Receptor Antagonists: An Overview - Medscape - Jul 01, 2000. Abstract and Introduction; The Renin-Angiotensin Receptor System; Inhibitors of the Renin- Angiotensin System; ...